Crystal structure of Ultralente - A microcrystalline insulin suspension

Proteins: Structure, Function and Bioinformatics

Volumn 74, Issue 4, 2009, Pages 1018-1027

  Wagner, Armin ^a,c   Diez, Joachim ^a   Schulze Briese, Clemens ^a   Schluckebier, Gerd ^b  

^a PAUL SCHERRER INSTITUTE   (Switzerland)

^b NOVO NORDISK A S   (Denmark)

^c DIAMOND LIGHT SOURCE LTD   (United Kingdom)

Author keywords

Insulin; Microcrystals; Microfocus beam

Indexed keywords

INSULIN ZINC SUSPENSION; METHYL PARABEN; ZINC ION; 4 HYDROXYBENZOIC ACID ESTER; ANTIDIABETIC AGENT; LONG ACTING INSULIN;

ARTICLE; BINDING SITE; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; DRUG MECHANISM; DRUG STRUCTURE; MICROCRYSTALLINE SUSPENSION; PRIORITY JOURNAL; X RAY DIFFRACTION; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; CRYSTALLIZATION; METABOLISM; PROTEIN CONFORMATION; X RAY CRYSTALLOGRAPHY;

BINDING SITES; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; HYPOGLYCEMIC AGENTS; INSULIN, LONG-ACTING; MODELS, MOLECULAR; PARABENS; PROTEIN CONFORMATION;

EID: 61449241757     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.22213     Document Type: Article

References (39)

1. Hallas-Møller K, Petersen K, Schlichtkrull J. Crystalline and amorpHous insulin-zinc compounds with prolonged action. Science 1952;116:394-399.
2. Schlichtkrull J. Insulin crystals. Copenhagen: Munksgaard; 1958.
3. Brange J. Galenics of insulin. Berlin Heidelberg: Springer-Verlag; 1987.
4. Yip CM, DeFelippis MR, Frank BH, Brader ML, Ward MD. Structural and morphological characterization of ultralente insulin crystals by atomic force microscopy: evidence of hydrophobically driven assembly. Biophys J 1998;75:1172-1179.
5. Lange RH, Blodorn J, Magdowski G, Trampisch HJ. Crystalline preparations of rhombohedral porcine insulin as studied by electron diffraction. J Ultrastruct Res 1979;68:81-91.
6. Norrman M, Stahl K, Schluckebier G, Al-Karadaghi S. Characterization of insulin microcrystals using powder diffraction and multivariate data analysis. J Appl Cryst 2006;39:391-400.
7. Richards JP, Stickelmeyer MP, Frank BH, Pye S, Barbeau M, Radziuk J, Smith GD, DeFelippis MR. Preparation of a microcrystalline suspension formulation of Lys(B28)pro(B29)-human insulin with ultralente properties. J Pharm Sci 1999;88:861-867.
8. Galloway JA, Chance RE. Approaches to insulin analogues. Diabetes Annu 1994;8:277-297.
9. Kaarsholm NC, Ko H-C, Dunn MF. Comparison of solution structural flexibility and zinc binding domains for insulin, proinsulin, and miniproinsulin. Biochemistry 1989;28:4427-4435.
10. Ciszak E, Beals JM, Frank BH, Baker JC, Carter ND, Smith GD. Role of C-terminal B-chain residues in insulin assembly: The structure of hexameric Lys-B28-Pro-B29-human insulin. Structure (London) 1995;3:615-622.
11. DeFelippis MR, Chance RE, Frank BH. Insulin self-association and the relationship to pharmacokinetics and pharmacodynamics. Crit Rev Ther Drug Carrier Syst 2001;18:201-264.
12. Basu SK, Govardhan CP, Jung CW, Margolin AL. Protein crystals for the delivery of biopharmaceuticals. Expert Opin Biol Ther 2004;4:301-317.
13. Brader ML, Sukumar M, Pekar AH, McClellan DS, Chance RE, Flora DB, Cox AL, Irwin L, Myers SR. Hybrid insulin cocrystals for controlled release delivery. Nat Biotechnol 2002;20:800-804.
14. Kabsch W. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. J Appl Cryst 1993;26:795-800.
15. Howlin B, Butler SA, Moss DS, Harris GW, Driessen HPC. Tlsanl - Tls Parameter-Analysis Program for Segmented Anisotropic Refinement of Macromolecular Structures. J Appl Crystallogr 1993;26: 622-624.
16. Navaza J. Implementation of molecular replacement in AMoRe. Acta Cryst 2001;57:1367-1372.
17. Ciszak E, Smith GD. Crystallographic evidence for dual coordination around zinc in the T3R3 human insulin hexamer. Biochemistry 1994;33:1512-1517.
18. Smith GD, Pangborn WA, Blessing RH. The structure of T6 human insulin at 1.0 A resolution. Acta Crystallogr D 2003;59:474-482.
19. Murshudov GN, Vagin AA, Dodson EJ. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D 1997;53:240-255.
20. Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D 2004;60:2126-2132.
21. Winn MD, Isupov MN, Murshudov GN. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr D 2001;57:122-133.
22. DeLano WL. The PyMOL molecular graphics system. San Carlos, CA, USA: DeLano Scientific; 2002. Ref Type: Computer Program
23. Hope H. Cryocrystallography of biological macromolecules: a generally applicable method. Acta Crystallogr B 1988;44(Part 1):22-26.
24. Thorne RE. Microfabricated mounts for high-throughput macromolecular cryocrystallography. J Appl Crystallogr 2003;36:1455.
25. Smith GD, Swenson DC, Dodson EJ, Dodson GG, Reynolds CD. Structural stability in the 4-zinc human insulin hexamer. Proc Natl Acad Sci USA 1984;81:7093-7097.
26. Baker EN, Blundell TL, Cutfield JF, Cutfield SM, Dodson EJ, Dodson GG, Hodgkin DM, Hubbard RE, Isaacs NW, Reynolds CD, Sakabe K, Sakabe N, Vijayan NM. The structure of 2Zn pig insulin crystals at 1.5 A resolution. Philos Trans R Soc Lond B Biol Sci 1988;319:369-456.
27. 2+ in the assembly, stability, and storage of the insulin hexamer. Biochemistry 1991;30:917-924.
28. Dunn MF. Zinc-ligand interactions modulate assembly and stability of the insulin hexamer - a review. Bio Metals 2005;18:295-303.
29. Emdin SO, Dodson GG, Cutfield JM, Cutfield SM. Role of zinc in insulin biosynthesis. Some possible zinc-insulin interactions in the pancreatic B-cell. Diabetologia 1980;19:174-182.
30. Smith GD, Ciszak E, Magrum LA, Pangborn WA, Blessing RH. R6 hexameric insulin complexed with m-cresol or resorcinol. Acta Crystallogr 2000;56:1541-1548.
31. Norrman M, Schluckebier G. Crystallographic characterization of two novel crystal forms of human insulin induced by chaotropic agents and a shift in pH. BMC Struct Biol 2007;7:83.
32. Whittingham JL, Chaudhuri S, Dodson EJ, Moody PC, Dodson GG. X-ray crystallographic studies on hexameric insulins in the presence of helix-stabilizing agents, thiocyanate, methylparaben, and phenol. Biochemistry 1995;34:15553-15563.
33. Bentley G, Dodson G, Lewitova A. Rhombohedral insulin crystal transformation. J Mol Biol 1978;126:871-875.
34. Reynolds CD. Preliminary study of a phase transformation in insulin crystals using synchrotron-radiation Laue diffraction. Acta Crystallogr B 1988;44:512.
35. Chothia C, Lesk AM, Dodson GG, Hodgkin DC. Transmission of conformational change in insulin. Nature 1983;302:500-505.
36. Bentley G, Dodson E, Dodson G, Hodgkin D, Mercola D. Structure of insulin in 4-zinc insulin. Nature 1976;261:166-168.
37. Kaarsholm NC, Havelund S, Hougaard P. Ionization behavior of native and mutant insulins: pK perturbation of B13-Glu in aggregated species. Arch Biochem Biophys 1990;283:496-502.
38. Rasmussen SGF, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC, Burghammer M, Ratnala VRP, Sanishvili R, Fischetti RF, Schertler GFX, Weis WI, Kobilka BK. Crystal structure of the human β2 adrenergic G-protein-coupled receptor. Nature 2007;450:383-387.
39. Coulibaly F, Chiu E, Ikeda K, Gutmann S, Haebel PW, Schulze-Briese C, Mori H, Metcalf P. The molecular organization of cypovirus polyhedra. Nature 2007;446:97-101.